What are the appropriate indications, dosing guidelines, contraindications, and safety precautions for Pedicloryl (chloral hydrate) in pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pedicloryl (Chloral Hydrate) in Pediatric Patients

Pedicloryl (chloral hydrate) is indicated for children 6 to under 12 years at 2 mL every 6 hours (not exceeding 4 doses in 24 hours), but its use requires careful patient selection and continuous cardiopulmonary monitoring given the risk of respiratory depression, particularly in children under 2 years who face a black box warning for fatal respiratory complications. 1, 2

Indications and Appropriate Use

Chloral hydrate is primarily used for:

  • Procedural sedation for diagnostic imaging (MRI, CT) in children
  • Dental procedures requiring moderate sedation
  • Nocturnal sedation in pediatric patients

The drug is most effective in younger children (under 2 years) and lighter weight patients 3. Success rates for sedation reach 95-100% when proper dosing and patient selection criteria are followed 4, 5.

Dosing Guidelines

Standard Dosing

  • Initial dose: 40-60 mg/kg orally (standard dose range)
  • Reduced dose: <40 mg/kg (does not affect effectiveness but may increase failure rates) 4
  • High dose: >60 mg/kg (may be needed in specific populations)
  • Additional dose: 10-20 mg/kg can be given 15 minutes after initial dose if needed 4

FDA-Approved Dosing (Pedicloryl)

For children 6 to under 12 years: 2 mL every 6 hours, maximum 4 doses in 24 hours 1. For children under 6 years, physician consultation is required 1.

Route-Specific Considerations

Rectal administration achieves comparable success rates (84%) to oral administration (91%) but with significantly shorter onset time (6.36 minutes faster) and zero vomiting rate versus 20% with oral route 6, 7. The rectal route provides a viable alternative when oral administration is problematic.

Patient Selection Criteria

Appropriate Candidates

  • ASA Class I and II patients are ideal candidates 2
  • Outpatients, patients undergoing hearing screening, and those with sleep deprivation have higher success rates 3
  • Younger children (<2 years) and lighter weight patients respond more predictably 8, 3

High-Risk Patients Requiring Additional Consideration

Children with the following characteristics have 2.2 times higher likelihood of requiring additional doses:

  • Age >2 years 4
  • Heavier weight 3
  • History of previous sedation or sedation failure 3
  • Undergoing MRI or multiple procedures simultaneously 3

ASA Class III-IV patients, children with anatomic airway abnormalities, or moderate-to-severe tonsillar hypertrophy require individual assessment and may not be appropriate candidates 2.

Critical Contraindications and Warnings

Black Box Warning

Promethazine (often combined with chloral hydrate) carries a black box warning for fatal respiratory depression in children under 2 years 2. This combination should be avoided in this age group.

Absolute Contraindications (per FDA label)

Do not use if the child has:

  • Breathing problems (emphysema, chronic bronchitis) 1
  • Glaucoma 1

Relative Contraindications

  • Concurrent use of sedatives or tranquilizers (increases drowsiness effect) 1
  • Compromised or ill preterm infants (risk of trichloroacetic acid and trichloroethanol accumulation) 9

Safety Precautions and Monitoring Requirements

Mandatory Monitoring Standards

Continuous monitoring by personnel trained in pediatric advanced life support is required from drug administration until discharge criteria are met 2, 5. This includes:

  • Continuous pulse oximetry (SpO2)
  • Vital signs monitoring
  • Respiratory rate and pattern assessment
  • Level of consciousness

Emergency Preparedness

An emergency cart with age-appropriate equipment must be immediately accessible, including:

  • Oral and nasal airways
  • Bag-valve-mask device
  • Laryngoscope blades and tracheal tubes
  • Supraglottic devices (LMAs)
  • Intravenous catheters
  • Blood pressure cuffs 2

For non-hospital facilities, a protocol for immediate EMS activation must be established 2.

Adverse Events and Management

Common Adverse Events

  • Hypoxia (mild: SpO2 90-95%): Occurs in 5-9% of cases, usually resolves spontaneously 5
  • Prolonged sedation: Most common postoperative event 10
  • Vomiting: 20% with oral route, 0% with rectal route 6
  • Paradoxical excitability: Especially in children 1

Serious Adverse Events

Severe respiratory complications (SpO2 <85%) occur in <1% of cases but can be life-threatening 5. Deaths have been reported, primarily due to:

  • Dosing errors
  • Use of multiple sedatives
  • Inadequate patient selection (underestimated severity of underlying disease) 10, 5

Critical Pitfall

Re-sedation after discharge can occur due to prolonged drug effects, particularly dangerous in infants transported in car safety seats where airway obstruction may develop 2. Two adults should accompany children in car seats during transport.

Special Populations

Neonates and Infants

Use with extreme caution in preterm infants due to:

  • Accumulation of trichloroacetic acid and trichloroethanol in compromised infants
  • Competition for hepatic glucuronidation with bilirubin
  • Frequent serum bilirubin monitoring is mandatory with multiple dosing 9

Combination Therapy

Low-dose chloral hydrate (10-25 mg/kg) combined with other sedating medications is commonly used in pediatric dental practice 2, but this increases risk and requires heightened vigilance for respiratory depression.

Discharge Criteria

Two adults must accompany children still in car safety seats 2. Patients must meet standard recovery criteria before discharge, but extended observation is necessary given chloral hydrate's prolonged duration of action compared to shorter-acting agents.

Key Clinical Pearls

  • Titrate to effect: Wait for full effect of previous dose (peak EEG effect at ~4.8 minutes for midazolam comparison) before additional dosing 2
  • Sleep deprivation improves success rates 3
  • Reduced doses (<50 mg/kg) do not increase failure rates but standard dosing (40-60 mg/kg) remains preferred 4
  • Rectal route eliminates vomiting risk and provides faster onset 6, 7
  • Success rate drops significantly for MRI procedures and multiple simultaneous procedures - consider alternative agents 3

Related Questions

What are the recommended oral and intravenous dosing regimens for chloral hydrate in adults, children, and elderly patients, including maximum daily doses and adjustments for hepatic or renal impairment?
What is chloral hydrate?
What is the dose of chloral hydrate for pediatric sedation?
What is the appropriate dose of hydroxyzine for a 9‑year‑old child?
What medication can be given to a 2‑year‑old child before a head CT in a hospital that does not permit conscious sedation?
In a patient with pelvic‑floor hypertonicity, should treatment target trigger points in the internal anal sphincter or scar tissue in the perineal/posterior pelvic region?
How should a non-weight-bearing 5-year-old girl with a lateral ankle sprain and a negative preliminary X-ray be treated?
How should I manage post‑surgical pelvic‑floor muscle spasm that is easily triggered and interferes with parasympathetic function?
How does a heart failure clinic assess and manage a new patient with elevated left‑ventricular end‑diastolic pressure (~24 mm Hg), elevated pulmonary capillary wedge pressure (~18 mm Hg), preserved ejection fraction (~60 %), relative wall thickness 0.44, presenting with orthopnea, peripheral edema, and chronic dry cough?
What are the recommended fentanyl dosing guidelines for pediatric patients, including intravenous dose, procedural sedation dose, continuous infusion rate, and transdermal patch restrictions?
What laboratory tests should be ordered for a 69-year-old woman with fatigue and a history of hypothyroidism?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.